ABBV-932

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AdultGeneralized Anxiety Disorder

127 competitors in Adult

#DrugCompanyPhaseTrials

1

Nydrazid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

12

Tebrazid

AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Phase 3

13

Mounjaro

Eli Lilly

Phase 2

14

Rifampicin

Boehringer Ingelheim

Phase 3

35

Myqorzo

CCytokinetics

Phase 3

16

Opzelura

DDizal Pharmaceuticals

Phase 2

17

NM8074

NNovelMed Therapeutics

Phase 2

28

EB-1020

Otsuka

Phase 3

19

Rhuph20

Bristol-Myers Squibb

Phase 1

210

ABBV-932

AbbVie

Phase 2

2Show 28 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Adverse Events3 trials

Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants

Completed·AbbVie·Phase 1·NCT07024797·20 enrolled

Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

Completed·AbbVie·Phase 1·NCT05738850·104 enrolled

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

Completed·AbbVie·Phase 2·NCT06605599·161 enrolled

Generalized Anxiety Disorder2 trials

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)

Completed·AbbVie·Phase 1·NCT06024239·72 enrolled

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Recruiting·AbbVie·Phase 2·NCT06846320·315 enrolled

Adult2 trials

Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Volunteers

Completed·AbbVie·Phase 1·NCT06300580·11 enrolled

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

Active, not recruiting·AbbVie·Phase 1·NCT06849791·9 enrolled

Depressive Episodes1 trial

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

Recruiting·AbbVie·Phase 2·NCT07220460·200 enrolled

Bipolar Disorder1 trial

A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of ABBV-932 in Adult Subjects With Bipolar Disorder

Recruiting·AbbVie·Phase 1·NCT07071532·20 enrolled

1 more indication

Unspecified1 trial

Mass Balance Study of [14C] ABBV-932 Following Single Oral Dose Administration in Healthy Male Volunteers

Active, not recruiting·AbbVie·Phase 1·NCT06953934·8 enrolled

Details

Drug Info

Related News